Axsome Therapeutics, Inc.

Historical 13F Holders

Symbol
AXSM
CUSIP
05464T104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 05464T104 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 5.3% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
RTW Investments, LP 13G/A
3.1% 8/14/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 42 488 k $89.5 M
2026 Q2 542 49.8 M $9.81 B
2026 Q1 435 37.9 M $6.41 B
2025 Q4 430 37.7 M $6.87 B
2025 Q3 388 37.4 M $4.55 B
2025 Q2 377 38.1 M $3.97 B
2025 Q1 389 37.6 M $4.38 B
2024 Q4 329 37.2 M $3.15 B
2024 Q3 317 38.9 M $3.49 B
2024 Q2 283 41.3 M $3.32 B
2024 Q1 292 40.9 M $3.25 B
2023 Q4 278 39.6 M $3.15 B
2023 Q3 257 37.9 M $2.65 B
2023 Q2 263 36.4 M $2.62 B
2023 Q1 222 31.9 M $1.97 B
2022 Q4 254 30.8 M $2.38 B
2022 Q3 220 25.8 M $1.15 B
2022 Q2 206 21.6 M $827 M
2022 Q1 200 19.1 M $793 M
2021 Q4 202 18.8 M $712 M
2021 Q3 202 19.1 M $627 M
2021 Q2 198 22.9 M $1.55 B
2021 Q1 204 23.1 M $1.31 B
2020 Q4 206 24.1 M $1.96 B
2020 Q3 196 24.1 M $1.71 B
2020 Q2 215 24.3 M $2.00 B
2020 Q1 198 22.9 M $1.35 B
2019 Q4 200 22.7 M $2.35 B
2019 Q3 125 18.9 M $387 M
2019 Q2 126 18.4 M $479 M
2019 Q1 83 14.8 M $216 M
2018 Q4 40 3.92 M $11.1 M
2018 Q3 36 3.53 M $12.2 M
2018 Q2 37 4.10 M $13.1 M
2018 Q1 37 4.23 M $10.4 M
2017 Q4 37 5.82 M $32.6 M
2017 Q3 31 6.01 M $33.3 M
2017 Q2 35 6.40 M $35.3 M
2017 Q1 51 7.77 M $30.3 M
2016 Q4 42 6.22 M $42.0 M
2016 Q3 36 6.31 M $49.7 M
2016 Q2 34 5.80 M $43.7 M
2016 Q1 17 5.26 M $45.2 M
2015 Q4 11 5.22 M $47.7 M